Utah Medical Products, Inc.

NasdaqGS:UTMD 株式レポート

時価総額:US$230.6m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Utah Medical Products マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Kevin Cornwell

最高経営責任者

US$510.6k

報酬総額

CEO給与比率29.8%
CEO在任期間31.8yrs
CEOの所有権5.4%
経営陣の平均在職期間データなし
取締役会の平均在任期間27.7yrs

経営陣の近況

Recent updates

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Aug 06
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Utah Medical Products: An Attractive, But Speculative, Prospect

Mar 22

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Feb 09
Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Dec 13
Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Nov 23
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30

Nov 03
Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295

Aug 28
Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295

Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?

Mar 04
Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295

Feb 10
Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295

A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)

Jan 11
A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)

Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29

Aug 08
Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29

Utah Medical Products declares $0.29 dividend

Aug 02

Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M

Jul 26

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

May 14
Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29

Feb 26
Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Feb 12
Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital

Sep 28
Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28

Aug 06
Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28

Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation

May 01
Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation

Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?

Mar 26
Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?

Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital

Mar 02
Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 11
Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain

Jan 27
Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain

Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?

Jan 13
Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?

Dec 29
Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?

Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?

Dec 15
Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?

Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?

Nov 30
Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?

Utah Medical Products declares $0.285 dividend

Nov 03

CEO報酬分析

Utah Medical Products の収益と比較して、Kevin Cornwell の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

US$16m

Mar 31 2024n/an/a

US$16m

Dec 31 2023US$511kUS$152k

US$17m

Sep 30 2023n/an/a

US$17m

Jun 30 2023n/an/a

US$17m

Mar 31 2023n/an/a

US$17m

Dec 31 2022US$452kUS$84k

US$16m

Sep 30 2022n/an/a

US$16m

Jun 30 2022n/an/a

US$16m

Mar 31 2022n/an/a

US$15m

Dec 31 2021US$494kUS$156k

US$15m

Sep 30 2021n/an/a

US$14m

Jun 30 2021n/an/a

US$13m

Mar 31 2021n/an/a

US$11m

Dec 31 2020US$327kUS$78k

US$11m

Sep 30 2020n/an/a

US$12m

Jun 30 2020n/an/a

US$13m

Mar 31 2020n/an/a

US$15m

Dec 31 2019US$474kUS$156k

US$15m

Sep 30 2019n/an/a

US$14m

Jun 30 2019n/an/a

US$17m

Mar 31 2019n/an/a

US$18m

Dec 31 2018US$501kUS$156k

US$19m

Sep 30 2018n/an/a

US$13m

Jun 30 2018n/an/a

US$10m

Mar 31 2018n/an/a

US$9m

Dec 31 2017US$501kUS$156k

US$9m

報酬と市場: Kevinの 総報酬 ($USD 510.57K ) は、 US市場 ($USD 1.58M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Kevinの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Kevin Cornwell (77 yo)

31.8yrs

在職期間

US$510,570

報酬

Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah...


取締役

名称ポジション在職期間報酬所有権
Kevin Cornwell
Chairman31.7yrsUS$510.57k5.42%
$ 12.5m
Paul Richins
Independent Director26.7yrsUS$29.40k0.61%
$ 1.4m
Ernst Hoyer
Independent Lead Director28.7yrsUS$37.80k0.14%
$ 331.6k
Barbara Payne
Independent Director27.7yrsUS$29.40k0.14%
$ 320.8k
James Beeson
Independent Director17.6yrsUS$29.40k0.38%
$ 870.3k

27.7yrs

平均在職期間

77yo

平均年齢

経験豊富なボード: UTMDの 取締役会 は経験豊富で 経験豊富 です ( 27.4年の平均在任期間)。